SCHEMBL27225820

SCHEMBL27225820

O=C1CCC(N2Cc3cc(N4CCN(C5CNC5)CC4)ccc3C2=O)C(=O)N1OC(=O)C(F)(F)F

nearest known ligand 0.35

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ CRBN Q96SW2 10/20 0.35
▸ IKZF2 Q9UKS7 5/20 0.34
▸ GSPT1 P15170 2/20 0.34
▸ DDB1 Q16531 2/20 0.34
▸ CYP2C19 P33261 1/20 0.34
▸ KCNH2 Q12809 1/20 0.34
▸ ESR1 P03372 2/20 0.34
▸ WIZ O95785 2/20 0.34
▸ HTR2A P28223 2/20 0.33
▸ HTR2C P28335 2/20 0.33
▸ HTR2B P41595 2/20 0.33
▸ CSNK1A1 P48729 3/20 0.32
▸ HTR7 P34969 1/20 0.31
▸ TMEM97 Q5BJF2 2/20 0.31
▸ SIGMAR1 Q99720 2/20 0.31
▸ CHRM4 P08173 1/20 0.31
▸ HTR1A P08908 1/20 0.31
▸ CHRM5 P08912 1/20 0.31
▸ ADRA2A P08913 1/20 0.31
▸ ADRA2B P18089 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Trifluoroacetic Acid SCHEMBL27231854 0.79 IKZF2 (0.54) CRBNIKZF2GSPT1DDB1CYP2C19
SCHEMBL27302543 0.75 CRBN (0.59) CRBNIKZF2ESR1WIZCSNK1A1
SCHEMBL24675552 0.75 CRBN (0.59) CRBNIKZF2ESR1WIZCSNK1A1
SCHEMBL27424055 0.73 IKZF2 (0.56) CRBNIKZF2ESR1WIZCSNK1A1
SCHEMBL28638497 0.71 IKZF2 (0.66) IKZF2
SCHEMBL27302697 0.71 CRBN (0.55) CRBNIKZF2ESR1WIZCSNK1A1
SCHEMBL26495770 0.70 CRBN (0.38) CRBNIKZF2ESR1WIZHTR2A
SCHEMBL22557823 0.70 CRBN (0.32) CRBNIKZF2GSPT1DDB1CYP2C19
SCHEMBL26101937 0.70 KDM4E (0.32) CRBNDDB1
SCHEMBL20235035 0.70 CRBN (0.56) CRBNIKZF2ESR1WIZCSNK1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20240174637-A1 DEGRADERS OF GRK2 AND USES THEREOF PIIZZI GRAZIA (US) 2024-05-30 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20240174637-A1 DEGRADERS OF GRK2 AND USES THEREOF GRK2, GRK3, GRK1 CRBN 1066/4885IKZF2 3569/4885GSPT1 568/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback